Development Programs Jobs in Menlo Park, CA
-
Job Type
-
Posting Date
5 Jobs Found | Sort By : Relevance | Posted Date
Less results matching your search!
Try removing some of the filters to get more results
No results matching your search!
Try removing some of the filters to get more results
Executive Hrbp
Hello Heart
About Hello Heart:Hello Heart is on a mission to change the way people care for their hearts. The company provides the first app and connected heart monitor to help people track and manage their heart health. With Hello Heart users take steps to control their risk of heart attacks and stroke the le...
Senior Project Manager
Summit Therapeutics Sub
About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...
Director Of People Support (human Resources)
Hersha Hospitality Management Lp
OverviewOpportunity: Director of Human ResourcesHotel Nia is a contemporary luxury property defined by excellence in service and a culture of genuine connection. Were seeking a Director of Human Resources who brings both strategic insight and a people-first mindset. This leader will oversee all face...
Associate Director, Project Management
Summit Therapeutics Sub
About Summit: Ivonescimab known as SMT112 is a novel potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooper...
Associate Director, Project Manager
Summit Therapeutics Sub
About Summit: Ivonescimab known as SMT112 is a novel potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooper...